| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Orchard Therapeutics (NASDAQ:ORTX) reported its Q3 earnings results on Monday, November 13, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Orchard Therapeutics beat estimated earnings by 80.0%, reporting an EPS of $-0.15 versus an estimate of $-0.75.
Revenue was down $218 thousand from the same period last year.
Last quarter the company beat on EPS by $1.6 which was followed by a 1.72% increase in the share price the next day.
To track all earnings releases for Orchard Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ORTX
